SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (19)1/13/2001 12:27:27 AM
From: prophet_often  Read Replies (1) | Respond to of 897
 
Agree on IMNX, locked in a downtrend, expensive and has not bounced very well so far this year.

stockcharts.com[W,A]DACLYYMY[DC][PB40][VC60][IUC20!UM12!UO14!LH14,3]

Read something in the Pink Sheets a while back about some adverse effects seen with Enbrel, and possible future competition from Amgen's IL-1 receptor agonist.